2019冠状病毒病大流行期间的癌症护理管理：来自北非单一中心的简要报告
Managing cancer care during the COVID-19 pandemic: brief report from a North African single center.
作者信息
Benhima Nada, Kaakoua Mohamed, Rachidi Siham Alaoui, Fadli Mohamed El, Belbaraka Rhizlane
机构信息
Medical Oncology Department, Mohammed VI University Hospital, Marrakech, Morocco.
Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco.
出版信息
Pan Afr Med J. 2020 Jul 29;35(Suppl 2):127. doi: 10.11604/pamj.supp.2020.35.25020. eCollection 2020.
Abstract
The potential threat of COVID-19 pandemic on the continuity of care for cancer patients is thought to be significant. Oncologists are weighing up the balance of risks and benefits carefully when planning daily cancer care and making treatment decisions in the face of rapid change during this public health crisis. This report describes management strategies and care models that have been adopted by a single Medical Oncology department in a North Africa, Morocco.
摘要
2019年冠状病毒病大流行对癌症患者持续护理的潜在威胁被认为很大。在这场公共卫生危机期间，面对迅速变化的情况，肿瘤学家在规划日常癌症护理和做出治疗决策时，正在仔细权衡风险和益处。本报告描述了北非摩洛哥一个单一的医学肿瘤学部门所采用的管理策略和护理模式。
相似文献
1
Managing cancer care during the COVID-19 pandemic: brief report from a North African single center.2019冠状病毒病大流行期间的癌症护理管理：来自北非单一中心的简要报告
Pan Afr Med J. 2020 Jul 29;35(Suppl 2):127. doi: 10.11604/pamj.supp.2020.35.25020. eCollection 2020.
2
COVID-19 infection and dermatologic surgery: management in a dermo-oncology center in a high-risk pandemic area.2019冠状病毒病感染与皮肤科手术：高危大流行地区皮肤肿瘤中心的管理
G Ital Dermatol Venereol. 2020 Oct;155(5):684-685. doi: 10.23736/S0392-0488.20.06680-8. Epub 2020 Oct 21.
3
COVID-19 and cancer care: What have we learned?: Despite the enormous challenges, researchers are sharing valuable lessons regarding evaluating risks, setting priorities, and communicating with patients during the pandemic.新冠疫情与癌症护理：我们学到了什么？尽管面临巨大挑战，但研究人员正在分享有关在疫情期间评估风险、确定优先事项以及与患者沟通的宝贵经验教训。
Cancer Cytopathol. 2020 Dec;128(12):879-880. doi: 10.1002/cncy.22394.
4
Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study.COVID-19大流行期间的癌症护理差异：COVID-19与癌症结局研究
Cancer Cell. 2020 Dec 14;38(6):769-770. doi: 10.1016/j.ccell.2020.10.023. Epub 2020 Nov 3.
5
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research.在 COVID-19 大流行期间管理日本胃肠道肿瘤学实践：日本癌症研究基金会癌症研究所医院的单机构经验。
Int J Clin Oncol. 2021 Feb;26(2):335-344. doi: 10.1007/s10147-020-01806-7. Epub 2020 Oct 21.
6
Challenges of Cancer Immunotherapy during the COVID-19 Pandemic.新冠疫情期间癌症免疫疗法面临的挑战
Cancer Invest. 2021 Feb;39(2):115-119. doi: 10.1080/07357907.2020.1864129. Epub 2020 Dec 27.
7
[Surgical management of cancer patients within the COVID-19 pandemic].[COVID-19大流行期间癌症患者的外科治疗]
Khirurgiia (Mosk). 2020(12):5-15. doi: 10.17116/hirurgia20201215.
8
COVID-19 in patients with cancer: managing a pandemic within a pandemic.癌症患者中的 COVID-19：在大流行中管理大流行。
Nat Rev Clin Oncol. 2021 Jan;18(1):1-2. doi: 10.1038/s41571-020-00441-5.
9
Uncertainty from COVID-19 delays progress on the road to value-based cancer care.新冠疫情带来的不确定性延缓了通向基于价值的癌症治疗之路。
Am J Manag Care. 2020 Oct;26(8 Spec No.):SP251-SP252. doi: 10.37765/ajmc.2020.88565.
10
Skin cancers: how to balance the risks and benefits of surgery during COVID-19 pandemic (a Northern Italy single-center experience).皮肤癌：在新冠疫情期间如何权衡手术的风险与益处（意大利北部单中心经验）
Int J Dermatol. 2020 Oct;59(10):1287-1289. doi: 10.1111/ijd.15086. Epub 2020 Aug 9.
本文引用的文献
1
Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence.癌症患者和 COVID-19 大流行期间的研究：当前证据的系统评价。
Crit Rev Oncol Hematol. 2020 Jun;150:102972. doi: 10.1016/j.critrevonc.2020.102972. Epub 2020 Apr 22.
2
Managing COVID-19 in the oncology clinic and avoiding the distraction effect.肿瘤诊所中新冠病毒病的管理及避免干扰效应
Ann Oncol. 2020 May;31(5):553-555. doi: 10.1016/j.annonc.2020.03.286. Epub 2020 Mar 19.
3
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
4
Does delayed initiation of adjuvant chemotherapy following the curative resection affect the survival outcome of gastric cancer patients: A systematic review and meta-analysis.根治性切除术后辅助化疗延迟起始是否影响胃癌患者的生存结局：系统评价和荟萃分析。
Eur J Surg Oncol. 2020 Jun;46(6):1103-1110. doi: 10.1016/j.ejso.2020.01.013. Epub 2020 Jan 8.
5
[Report of cancer epidemiology in China, 2015].《2015年中国癌症流行病学报告》
Zhonghua Zhong Liu Za Zhi. 2019 Jan 23;41(1):19-28. doi: 10.3760/cma.j.issn.0253-3766.2019.01.005.
6
Survival and time to initiation of adjuvant chemotherapy among breast cancer patients: a systematic review and meta-analysis.乳腺癌患者的生存情况及辅助化疗开始时间：一项系统评价和荟萃分析。
Oncotarget. 2017 Dec 7;9(2):2739-2751. doi: 10.18632/oncotarget.23086. eCollection 2018 Jan 5.
7
XELOX vs. FOLFOX in metastatic colorectal cancer: An updated meta-analysis.XELOX方案与FOLFOX方案治疗转移性结直肠癌的比较：一项更新的荟萃分析。
Cancer Invest. 2016;34(2):94-104. doi: 10.3109/07357907.2015.1104689. Epub 2016 Feb 11.
8
Comparison of weekly versus every 3 weeks paclitaxel in the treatment of advanced solid tumors: a meta-analysis.每周紫杉醇与每 3 周紫杉醇治疗晚期实体瘤的比较：一项荟萃分析。
Cancer Treat Rev. 2012 Oct;38(6):613-7. doi: 10.1016/j.ctrv.2011.10.008. Epub 2011 Dec 10.
Zotero 插件